{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T16:00:58Z","timestamp":1753891258872,"version":"3.41.2"},"reference-count":16,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,12,14]],"date-time":"2022-12-14T00:00:00Z","timestamp":1670976000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"DOI":"10.3389\/fmed.2022.1052618","type":"journal-article","created":{"date-parts":[[2022,12,14]],"date-time":"2022-12-14T09:48:35Z","timestamp":1671011315000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Editorial: Risk factors for Rheumatoid Arthritis and pre-Rheumatoid Arthritis"],"prefix":"10.3389","volume":"9","author":[{"given":"Emillie","family":"Sapart","sequence":"first","affiliation":[]},{"given":"Margarida","family":"Faria","sequence":"additional","affiliation":[]},{"given":"Stephanie","family":"Dierckx","sequence":"additional","affiliation":[]},{"given":"Patrick","family":"Durez","sequence":"additional","affiliation":[]},{"given":"Jo\u00e3o Eurico","family":"Fonseca","sequence":"additional","affiliation":[]}],"member":"1965","published-online":{"date-parts":[[2022,12,14]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1136\/annrheumdis-2016-209846","article-title":"EULAR definition of arthralgia suspicious for progression to rheumatoid arthritis","volume":"76","author":"van Steenbergen","year":"2017","journal-title":"Ann Rheum Dis."},{"key":"B2","doi-asserted-by":"publisher","first-page":"1824","DOI":"10.1136\/annrheumdis-2015-208138","article-title":"Clinical factors, anticitrullinated peptide antibodies and MRI-detected subclinical inflammation in relation to progression from clinically suspect arthralgia to arthritis","volume":"75","author":"van Steenbergen","year":"2016","journal-title":"Ann Rheum Dis."},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2020-eular.1697","article-title":"FRI0542 Obtaining high positive predictive values for the development of clinically apparent arthritis in patients presenting with clinically suspect arthralgia; is it feasible?","author":"Matthijssen","year":"2020","journal-title":"Ann Rheum Dis"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1136\/annrheumdis-2012-203165","article-title":"Drug therapy in undifferentiated arthritis: a systematic literature review","volume":"72","author":"Wevers-de Boer","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"B5","doi-asserted-by":"publisher","first-page":"3212","DOI":"10.1093\/rheumatology\/keab880","article-title":"Undifferentiated arthritis: a changing population who did not benefit from enhanced disease-modifying anti-rheumatic drug strategies-results from a 25 year longitudinal inception cohort","volume":"61","author":"Verstappen","year":"2022","journal-title":"Rheumatology."},{"key":"B6","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/S0140-6736(22)01193-X","article-title":"Intervention with methotrexate in patients with arthralgia at risk of rheumatoid arthritis to reduce the development of persistent arthritis and its disease burden (TREAT EARLIER): a randomized, double-blind, placebo-controlled, proof-of-concept trial","volume":"400","author":"Krijbolder","year":"2022","journal-title":"Lancet."},{"unstructured":"Abatacept reverses subclinical arthritis in patients with high-risk to develop rheumatoid arthritis: results from the randomized, placebo-controlled ARIAA study in RA-at risk patients455\n            RechJ\n            OstergaardM\n            TascilarK\n            HagenM\n            ValorL\n            KleyerA\n          Am Coll Rheumatol Converg.20212021","key":"B7"},{"key":"B8","doi-asserted-by":"publisher","first-page":"707217","DOI":"10.3389\/fimmu.2021.707217","article-title":"Haplotype-specific expression analysis of MHC class II genes in healthy individuals and rheumatoid arthritis patients","volume":"12","author":"Houtman","year":"2021","journal-title":"Front Immunol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1902\/jop.2015.150455","article-title":"Periodontal disease in individuals with a genetic risk of developing arthritis and early rheumatoid arthritis: a cross-sectional study","volume":"87","author":"Bello-Gualtero","year":"2016","journal-title":"J Periodontol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1136\/ard.2008.096487","article-title":"Impact of smoking as a risk factor for developing rheumatoid arthritis: a meta-analysis of observational studies","volume":"69","author":"Sugiyama","year":"2010","journal-title":"Ann Rheum Dis."},{"key":"B11","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1007\/s10067-014-2569-3","article-title":"In palindromic rheumatism, hand joint involvement and positive anti-CCP antibodies predict RA development after 1 year of follow-up","volume":"33","author":"Emad","year":"2014","journal-title":"Clin Rheumatol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1136\/annrheumdis-2022-eular.4957","article-title":"POS0448 Synovial transcriptomic profiles correlate with disease activity in early untreated rheumatoid arthritis","volume":"81","author":"Triaille","year":"2022","journal-title":"Annal Rheumat Dis."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1642","DOI":"10.1136\/annrheumdis-2019-215751","article-title":"Synovial tissue signatures enhance clinical classification and prognostic\/treatment response algorithms in early inflammatory arthritis and predict requirement for subsequent biological therapy: results from the pathobiology of early arthritis cohort (PEAC)","volume":"78","author":"Lliso-Ribera","year":"2019","journal-title":"Ann Rheum Dis."},{"key":"B14","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1053\/sarh.2002.50004","article-title":"Diagnostic usefulness of synovial vascular morphology in chronic arthritis. A systematic survey of 100 cases","volume":"32","author":"Ca\u00f1ete","year":"2003","journal-title":"Semin Arthritis Rheum."},{"key":"B15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13075-017-1329-6","article-title":"Differing specificities and isotypes of anti-citrullinated peptide\/protein antibodies in palindromic rheumatism and rheumatoid arthritis","volume":"19","author":"Cabrera-Villalba","year":"2017","journal-title":"Arthritis Res Ther."},{"key":"B16","doi-asserted-by":"publisher","first-page":"2784","DOI":"10.1002\/art.22755","article-title":"An unexpectedly high frequency of MEFV mutations in patients with anti-citrullinated protein antibody-negative palindromic rheumatism","volume":"56","author":"Ca\u00f1ete","year":"2007","journal-title":"Arthritis Rheum."}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2022.1052618\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,14]],"date-time":"2022-12-14T09:48:38Z","timestamp":1671011318000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2022.1052618\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,14]]},"references-count":16,"alternative-id":["10.3389\/fmed.2022.1052618"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2022.1052618","relation":{},"ISSN":["2296-858X"],"issn-type":[{"type":"electronic","value":"2296-858X"}],"subject":[],"published":{"date-parts":[[2022,12,14]]},"article-number":"1052618"}}